Overexpression of α-synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis.
Adolfo Garcia ErustesFernanda Yakel StefaniJuliana Yoshie TerashimaRoberta Sessa StilhanoPriscila Totarelli MonteforteGustavo José da Silva PereiraSang Won HanAndrana Karla CalgarottoYi-Te HsuRodrigo Portes UreshinoCláudia BincolettoAdolfo Garcia ErustesPublished in: Journal of neuroscience research (2017)
α-Synuclein is the major component of neuronal cytoplasmic aggregates called Lewy bodies, the main pathological hallmark of Parkinson disease. Although neurons are the predominant cells expressing α-synuclein in the brain, recent studies have demonstrated that primary astrocytes in culture also express α-synuclein and regulate α-synuclein trafficking. Astrocytes have a neuroprotective role in several detrimental brain conditions; we therefore analyzed the effects of the overexpression of wild-type α-synuclein and its A30P and A53T mutants on autophagy and apoptosis. We observed that in immortalized astrocyte cell lines, overexpression of α-synuclein proteins promotes the decrease of LC3-II and the increase of p62 protein levels, suggesting the inhibition of autophagy. When these cells were treated with rotenone, there was a loss of mitochondrial membrane potential, especially in cells expressing mutant α-synuclein. The level of this decrease was related to the toxicity of the mutants because they show a more intense and sustained effect. The decrease in autophagy and the mitochondrial changes in conjunction with parkin expression levels may sensitize astrocytes to apoptosis.
Keyphrases
- cell cycle arrest
- induced apoptosis
- endoplasmic reticulum stress
- cell death
- oxidative stress
- wild type
- parkinson disease
- pi k akt
- signaling pathway
- cell proliferation
- transcription factor
- deep brain stimulation
- poor prognosis
- resting state
- spinal cord
- multiple sclerosis
- high resolution
- binding protein
- amino acid
- solid phase extraction
- blood brain barrier